Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
August 25, 2021 07:00 ET
|
Renovacor, Inc.
PHILADELPHIA, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating...
Renovacor Announces the Appointment of Elizabeth White, Ph.D., as Chief Business Officer and Senior Vice President of Operations
July 19, 2021 07:00 ET
|
Renovacor, Inc.
PHILADELPHIA, July 19, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating...
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
July 12, 2021 07:00 ET
|
Renovacor, Inc.
PHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating...
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
June 29, 2021 07:00 ET
|
Renovacor, Inc.
PHILADELPHIA, June 29, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating...
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer
June 02, 2021 07:00 ET
|
Renovacor, Inc.
PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...